Health Care & Life Sciences » Pharmaceuticals | Shenzhen Hepalink Pharmaceutical Co. Ltd.

Shenzhen Hepalink Pharmaceutical Co. Ltd.

Shenzhen Hepalink Pharmaceutical Co. Ltd.
Stock Exchange Shenzhen Stock Exchange
EPS
CNY0.85
Market Cap
CNY26.08 B
Shares Outstanding
1.25 B
Public Float
235.92 M

Profile

Address
No. 21 Langshan Road
Shenzhen Guangdong 518057
China
Employees -
Website http://www.hepalink.com
Updated 07/08/2019
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is engaged in the research, production and distribution of heparin sodium bulk drugs. It offers heparin sodium products, including Food and Drug Administration (FDA) grade heparin sodium ingredients and ordinary grade heparin sodium ingredients. The company was founded by Li Tan, Li Li and Shan Yu on April 21, 1998 and is headquartered in Shenzhen, China.

Financials

View All

Ze Hui Zheng
Chairman-Supervisory Board
Li Li
Chairman